Protective effects of tumor necrosis factor alpha inhibitors on methotrexate-induced pancreatic toxicity


Creative Commons License

Mercantepe T., Kalkan Y., Tumkaya L., Sehitoglu I., Mercantepe F., YILDIRMIŞ S.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, cilt.27, ss.715-720, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 27 Konu: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.17219/acem/68967
  • Dergi Adı: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
  • Sayfa Sayıları: ss.715-720

Özet

Background. Methotrexate (MTX), a folate antagonist, is commonly used in the treatment of many different types of cancer and inflammatory diseases, including pancreatic cancer, although its side effects on the pancreas have not yet been researched. The mechanism of MTX-induced toxicity is not well known, and it has been reported in high-dose toxicity studies that the pancreas is sensitive to toxic effects.